Early and late complications of hematopoietic stem cell transplantation

This publication has 75 references indexed in Scilit:

• aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
  Annals of Clinical and Translational Neurology, 2021
• Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
  Annals of Hematology, 2020
• Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation
  JAMA, 2019
• Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists
  Current Hematologic Malignancy Reports, 2019
• Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
  JAMA, 2019
• Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
  JAMA Neurology, 2017
• Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation
  Rheumatology International, 2016
• Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
  CNS Drugs, 2015
• High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
  JAMA Neurology, 2015
• Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
  JAMA, 2015